DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

DCB Bank, Dr Lal Path among Kotak Securities' top tech ideas; here's why

Business Standard 1 hr ago·28 Jul 2026, 2:41 am

Company Business Standard

Kotak Securities has identified DCB Bank and Dr. Lal PathLabs as key investment opportunities within the technology and healthcare sectors. The brokerage firm views these stocks as strong contenders for growth, leveraging their respective market positions and operational strengths.

For investors, this endorsement highlights the potential of these companies to deliver value. It suggests that these stocks are well-positioned to benefit from favorable market trends and robust business performance. This insight can help investors identify promising sectors and companies for their portfolios.

Investors should monitor the broader market conditions and the specific performance of these stocks. Keeping an eye on quarterly results and industry developments will be crucial to understanding how these companies are faring and whether they continue to meet the expectations set by analysts.